[시장보고서]유전자 합성 시장 규모, 점유율과 동향 분석 리포트 : 방법별, 서비스별, 용도별, 최종 용도별, 연구 단계별, 지역별, 부문 예측(2025-2033년)

유전자 합성 시장 규모, 점유율과 동향 분석 리포트 : 방법별, 서비스별, 용도별, 최종 용도별, 연구 단계별, 지역별, 부문 예측(2025-2033년)

Gene Synthesis Market Size, Share & Trends Analysis Report By Method, By Service, By Application, By End Use, By Research Phase, By Region, And Segment Forecasts, 2025 - 2033

상품코드 : 1869694

리서치사 : Grand View Research

발행일 : 2025년 10월

페이지 정보 : 영문 180 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,845,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,332,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,305,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

유전자 합성(연구 용도) 시장 요약

세계의 유전자 합성(연구 용도) 시장 규모는 2024년에 20억 9,000만 달러로 추정되며, 2033년까지 83억 9,000만 달러에 달할 것으로 예측됩니다.

2025-2033년에 CAGR 16.8%로 성장할 전망입니다. 합성생물학 분야 기업의 투자 급증과 정부의 지원적인 법령 및 규제가 시장 성장을 가속할 것으로 예측됩니다.

또한 유전자 합성 절차 및 기술의 발전도 예측 기간 중 서비스 수요를 촉진하고 있습니다. 예를 들어 2022년 4월 생명과학 연구 툴 및 서비스를 제공하는 GenScript는 이 분야에서 가장 진보된 DNA 합성용 반도체 칩을 출시할 것이라고 발표했습니다. 이 칩은 최고의 처리량을 제공합니다.

기술 발전이 가져온 빠르고 비용 효율적인 유전자 합성의 가능성

합성 생물학 기술의 발전은 유전자 합성(연구용)의 상황을 크게 변화시켜 보다 빠르고 정확하며 비용 효율적인 DNA 합성 과정을 실현하고 있습니다. 자동화, 오류 보정, 차세대 시퀀싱(NGS) 통합의 지속적인 개선으로 합성 유전자 구축의 정확성과 확장성이 향상되었습니다. 이러한 발전으로 인해 연구자들은 보다 짧은 시간 내에 복잡한 유전자 서열을 설계하고 합성할 수 있게 되어 처리 시간이 크게 단축되었습니다. 또한 AI 기반 설계 툴와 클라우드 기반 바이오인포매틱스 플랫폼의 통합은 워크플로우 효율성을 간소화하고, 연구 일정을 더욱 가속화하며, 수동 개입에 따른 비용을 절감할 수 있습니다.

하이스루풋 합성 플랫폼과 효소적 DNA 합성 플랫폼의 채택은 생산 능력을 더욱 강화하여 유전체학, 합성생물학, 단백질 엔지니어링 등 다양한 연구 용도를 위한 대규모 유전자 합성을 가능하게 했습니다. 이러한 기술 혁신은 합성 정확도를 향상시켰을 뿐만 아니라 오염 위험과 재료 낭비를 최소화했습니다. 그 결과, 연구기관과 생명공학 기업은 전임상시험, 표적 검증, mRNA 백신 및 유전자 치료와 같은 첨단 치료 후보물질의 개발을 지원하기 위해 이러한 진보를 점점 더 많이 활용하고 있습니다.

또한 유전자 합성 기술의 효율성과 경제성을 높이기 위한 지속적인 연구개발 노력이 예측 기간 중 시장 확대를 견인할 것으로 예측됩니다. 학계, 비상장 기업, 정부 연구기관 간 협력 강화로 더 긴 DNA 단편을 고정밀도로 생성할 수 있는 차세대 합성 플랫폼 개발이 진행되고 있습니다. 합성생물학, 진단, 정밀의료 등 다양한 응용 분야에서 맞춤형 유전자 구조체에 대한 수요가 지속적으로 증가함에 따라 합성생물학 기술의 발전은 세계 유전자 합성(연구용) 시장의 지속적인 성장을 이끄는 주요 원동력이 될 것입니다.

최종 용도별 부문 대시보드
세계의 유전자 합성(연구 용도) 시장 : 최종 용도별 변동 분석
세계의 유전자 합성(연구 용도) 시장 규모와 동향 분석, 최종 용도별, 2021-2033년
세계의 유전자 합성(연구 용도) 시장 : 최종 용도 변동 분석
바이오의약품 및 제약회사
학술기관 및 정부 연구기관
수탁 연구기관

제9장 유전자 합성(연구 용도) 시장 : 지역별 추정·동향 분석

유전자 합성(연구 용도) 시장 : 지역 전망
북미
- 미국
- 캐나다
- 멕시코
유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 사우디아라비아
- 남아프리카공화국
- 아랍에미리트
- 쿠웨이트

제10장 경쟁 구도

기업 분류
전략 지도제작
기업 포지션 분석, 2024
기업 개요/상장기업
- GenScript
- Azenta, Inc.(GENEWIZ)
- Boster Biological Technology
- Twist Bioscience
- ProteoGenix, Inc
- Biomatik.
- ProMab Biotechnologies, Inc.
- Thermo Fisher Scientific, Inc
- Integrated DNA Technologies, Inc.(Danaher)
- OriGene Technologies, Inc.

KSA

영문 목차

영문목차

Gene Synthesis (Research-use) Market Summary

The global gene synthesis (research-use) market size was estimated at USD 2.09 billion in 2024 and is projected to reach USD 8.39 billion by 2033, growing at a CAGR of 16.8% from 2025 to 2033. The surging investment by players in the synthetic biology field and supportive government laws & rules are expected to propel market growth.

Moreover, technological advances in gene synthesis procedures & techniques are also boosting the service demand over the forecast period. For instance, in April 2022, GenScript, a provider of life science research tools and services, announced the launch of the most advanced semiconductor chip for DNA synthesis in the field. This chip provides the highest throughput.

Technological Advancements Driving Faster and Cost-Efficient Gene Synthesis

Advancements in synthetic biology technologies are significantly transforming the gene synthesis (research-use) landscape, enabling faster, more accurate, and cost-efficient DNA synthesis processes. Continuous improvements in automation, error correction, and next-generation sequencing (NGS) integration have enhanced the precision and scalability of synthetic gene construction. These developments have substantially reduced turnaround times, allowing researchers to design and synthesize complex gene sequences within shorter timeframes. Moreover, the integration of AI-driven design tools and cloud-based bioinformatics platforms has streamlined workflow efficiency, further accelerated research timelines and reducing costs associated with manual interventions.

The adoption of high-throughput synthesis platforms and enzymatic DNA assembly methods has further strengthened production capabilities, enabling large-scale synthesis of genes for various research applications, including genomics, synthetic biology, and protein engineering. These technological innovations have not only improved synthesis accuracy but have also minimized contamination risks and material wastage. As a result, research institutions and biotechnology companies are increasingly leveraging these advancements to support pre-clinical studies, target validation, and the development of advanced therapeutic candidates such as mRNA vaccines and gene therapies.

Furthermore, ongoing R&D efforts aimed at enhancing the efficiency and affordability of gene synthesis technologies are expected to drive market expansion over the forecast period. The growing collaboration between academic institutions, private companies, and government research agencies is fostering the development of next-generation synthesis platforms capable of producing longer DNA fragments with higher fidelity. As the demand for customized genetic constructs continues to rise across applications in synthetic biology, diagnostics, and precision medicine, advancements in synthetic biology technologies are likely to remain a key driver supporting sustainable growth in the global gene synthesis (research-use) market.

Global Gene Synthesis (Research-Use) Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, grand view research has segmented the global gene synthesis (research-use) market report based on method, service, application, research phase, end use, and region.

Method Outlook (Revenue, USD Million, 2021 - 2033)
Solid-phase Synthesis
Chip-based Synthesis
PCR-based Enzyme Synthesis
Service Outlook (Revenue, USD Million, 2021 - 2033)
Antibody DNA Synthesis
Viral DNA Synthesis
Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
Gene & Cell Therapy Development
Vaccine Development
Others
Research Phase Outlook (Revenue, USD Million, 2021 - 2033)
Pre-clinical
Clinical
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Biotechnology and pharmaceutical companies
Academic and government research institutes
Contract research organizations
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
- 1.1.1. Method
- 1.1.2. Services
- 1.1.3. Application
- 1.1.4. Research Phase
- 1.1.5. End Use
1.2. Market Definitions
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
- 1.6.1. Primary Others
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
  - 3.3.1.1. Rising investment in synthetic biology market
  - 3.3.1.2. Advent of enzymatic DNA synthesis process
  - 3.3.1.3. Technological advancements in the DNA synthesis platforms
  - 3.3.1.4. Declining price of DNA synthesis & sequencing
- 3.3.2. Market Restraint Analysis
  - 3.3.2.1. Lack of skilled professionals
  - 3.3.2.2. Misuse of gene synthesis
3.4. Industry Analysis Tools
- 3.4.1. Porter's Five Forces Analysis
- 3.4.2. PESTLE Analysis

Chapter 4. Gene Synthesis (Research Use) Market: Method Estimates & Trend Analysis

4.1. Method Segment Dashboard
4.2. Global Gene Synthesis (Research Use) Market: Method Movement Analysis
4.3. Global Gene Synthesis (Research Use) Market Size & Trend Analysis, by Method, 2021 to 2033 (USD Million)
4.4. Solid-Phase Synthesis
- 4.4.1. Solid Phase Synthesis Market, 2021 - 2033 (USD Million)
4.5. Chip Based Synthesis
- 4.5.1. Chip Based Synthesis Market, 2021 - 2033 (USD Million)
4.6. PCR-based Enzyme Synthesis
- 4.6.1. PCR based Enzyme Synthesis Market, 2021 - 2033 (USD Million)

Chapter 5. Gene Synthesis (Research Use) Market: Services Estimates & Trend Analysis

5.1. Services Segment Dashboard
5.2. Global Gene Synthesis (Research Use) Market: Services Movement Analysis
5.3. Global Gene Synthesis (Research Use) Market Size & Trend Analysis, by Services, 2021 to 2033 (USD Million)
5.4. Antibody DNA Synthesis
- 5.4.1. Antibody DNA Synthesis Market, 2021 - 2033 (USD Million)
5.5. Viral DNA Synthesis
- 5.5.1. Viral DNA Synthesis Market, 2021 - 2033 (USD Million)
5.6. Others
- 5.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Gene Synthesis (Research Use) Market: Application Estimates & Trend Analysis

6.1. Application Segment Dashboard
6.2. Global Gene Synthesis (Research Use) Market: Application Movement Analysis
6.3. Global Gene Synthesis (Research Use) Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Gene & Cell Therapy Development
- 6.4.1. Gene & Cell Therapy Development Market, 2021 - 2033 (USD Million)
6.5. Vaccine Development
- 6.5.1. Vaccine Development Market, 2021 - 2033 (USD Million)
6.6. Others
- 6.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Gene Synthesis (Research Use) Market: Research Phase Estimates & Trend Analysis

7.1. Research Phase Segment Dashboard
7.2. Global Gene Synthesis (Research Use) Market: Research Phase Movement Analysis
7.3. Global Gene Synthesis (Research Use) Market Size & Trend Analysis, by Research Phase, 2021 to 2033 (USD Million)
7.4. Preclinical
- 7.4.1. Preclinical Market, 2021 - 2033 (USD Million)
7.5. Clinical
- 7.5.1. Clinical Market, 2021 - 2033 (USD Million)

Chapter 8. Gene Synthesis (Research Use) Market: End Use Estimates & Trend Analysis

8.1. End Use Segment Dashboard
8.2. Global Gene Synthesis (Research Use) Market: End Use Movement Analysis
8.3. Global Gene Synthesis (Research Use) Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
8.4. Global Gene Synthesis (Research Use) Market: End Use Movement Analysis
8.5. Biopharmaceutical & Pharmaceutical Companies
- 8.5.1. Biopharmaceutical & Pharmaceutical Companies Market, 2021 - 2033 (USD Million)
8.6. Academic & Government Research Institutes
- 8.6.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
8.7. Contract Research Organizations
- 8.7.1. Contract Research Organizations Market, 2021 - 2033 (USD Million)

Chapter 9. Gene Synthesis (Research Use) Market: Region Estimates & Trend Analysis

9.1. Gene Synthesis (Research Use) Market: Region Outlook
9.2. North America
- 9.2.1. North America gene synthesis (research use) market estimates and forecast, 2021 - 2033 (USD Million)
- 9.2.2. U.S.
  - 9.2.2.1. Key Country Dynamics
  - 9.2.2.2. Competitive Scenario
  - 9.2.2.3. Regulatory Framework
  - 9.2.2.4. U.S. gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
- 9.2.3. Canada
  - 9.2.3.1. Key Country Dynamics
  - 9.2.3.2. Competitive Scenario
  - 9.2.3.3. Regulatory Framework
  - 9.2.3.4. Canada gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
- 9.2.4. Mexico
  - 9.2.4.1. Key Country Dynamics
  - 9.2.4.2. Competitive Scenario
  - 9.2.4.3. Regulatory Framework
  - 9.2.4.4. Mexico gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
9.3. Europe
- 9.3.1. Europe gene synthesis (research use) market estimates and forecast, 2021 - 2033 (USD Million)
- 9.3.2. Germany
  - 9.3.2.1. Key Country Dynamics
  - 9.3.2.2. Competitive Scenario
  - 9.3.2.3. Regulatory Framework
  - 9.3.2.4. Germany gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
- 9.3.3. France
  - 9.3.3.1. Key Country Dynamics
  - 9.3.3.2. Competitive Scenario
  - 9.3.3.3. Regulatory Framework
  - 9.3.3.4. France gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
- 9.3.4. UK
  - 9.3.4.1. Key Country Dynamics
  - 9.3.4.2. Competitive Scenario
  - 9.3.4.3. Regulatory Framework
  - 9.3.4.4. UK gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
- 9.3.5. Italy
  - 9.3.5.1. Key Country Dynamics
  - 9.3.5.2. Competitive Scenario
  - 9.3.5.3. Regulatory Framework
  - 9.3.5.4. Italy gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
- 9.3.6. Spain
  - 9.3.6.1. Key Country Dynamics
  - 9.3.6.2. Competitive Scenario
  - 9.3.6.3. Regulatory Framework
  - 9.3.6.4. Spain gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
- 9.3.7. Denmark
  - 9.3.7.1. Key Country Dynamics
  - 9.3.7.2. Competitive Scenario
  - 9.3.7.3. Regulatory Framework
  - 9.3.7.4. Denmark gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
- 9.3.8. Sweden
  - 9.3.8.1. Key Country Dynamics
  - 9.3.8.2. Competitive Scenario
  - 9.3.8.3. Regulatory Framework
  - 9.3.8.4. Sweden gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
- 9.3.9. Norway
  - 9.3.9.1. Key Country Dynamics
  - 9.3.9.2. Competitive Scenario
  - 9.3.9.3. Regulatory Framework
  - 9.3.9.4. Norway gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
9.4. Asia Pacific
- 9.4.1. Asia Pacific gene synthesis (research use) market estimates and forecast, 2021 - 2033 (USD Million)
- 9.4.2. Japan
  - 9.4.2.1. Key Country Dynamics
  - 9.4.2.2. Competitive Scenario
  - 9.4.2.3. Regulatory Framework
  - 9.4.2.4. Japan gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
- 9.4.3. China
  - 9.4.3.1. Key Country Dynamics
  - 9.4.3.2. Competitive Scenario
  - 9.4.3.3. Regulatory Framework
  - 9.4.3.4. China gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
- 9.4.4. India
  - 9.4.4.1. Key Country Dynamics
  - 9.4.4.2. Competitive Scenario
  - 9.4.4.3. Regulatory Framework
  - 9.4.4.4. India gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
- 9.4.5. Australia
  - 9.4.5.1. Key Country Dynamics
  - 9.4.5.2. Competitive Scenario
  - 9.4.5.3. Regulatory Framework
  - 9.4.5.4. Australia gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
- 9.4.6. South Korea
  - 9.4.6.1. Key Country Dynamics
  - 9.4.6.2. Competitive Scenario
  - 9.4.6.3. Regulatory Framework
  - 9.4.6.4. South Korea gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
- 9.4.7. Thailand
  - 9.4.7.1. Key Country Dynamics
  - 9.4.7.2. Competitive Scenario
  - 9.4.7.3. Regulatory Framework
  - 9.4.7.4. Thailand gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
9.5. Latin America
- 9.5.1. Latin America gene synthesis (research use) market Estimates And Forecast, 2021 - 2033 (USD Million)
- 9.5.2. Brazil
  - 9.5.2.1. Key Country Dynamics
  - 9.5.2.2. Competitive Scenario
  - 9.5.2.3. Regulatory Framework
  - 9.5.2.4. Brazil gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
- 9.5.3. Argentina
  - 9.5.3.1. Key Country Dynamics
  - 9.5.3.2. Competitive Scenario
  - 9.5.3.3. Regulatory Framework
  - 9.5.3.4. Argentina gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
9.6. Middle East & Africa
- 9.6.1. Middle East & Africa gene synthesis (research use) market Estimates And Forecast, 2021 - 2033 (USD Million)
- 9.6.2. Saudi Arabia
  - 9.6.2.1. Key Country Dynamics
  - 9.6.2.2. Competitive Scenario
  - 9.6.2.3. Regulatory Framework
  - 9.6.2.4. Saudi Arabia gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
- 9.6.3. South Africa
  - 9.6.3.1. Key Country Dynamics
  - 9.6.3.2. Competitive Scenario
  - 9.6.3.3. Regulatory Framework
  - 9.6.3.4. South Africa gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
- 9.6.4. UAE
  - 9.6.4.1. Key Country Dynamics
  - 9.6.4.2. Competitive Scenario
  - 9.6.4.3. Regulatory Framework
  - 9.6.4.4. UAE gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)
- 9.6.5. Kuwait
  - 9.6.5.1. Key Country Dynamics
  - 9.6.5.2. Competitive Scenario
  - 9.6.5.3. Regulatory Framework
  - 9.6.5.4. Kuwait gene synthesis market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

10.1. Company Categorization
10.2. Strategy Mapping
10.3. Company Position Analysis, 2024
10.4. Company Profiles/Listing
- 10.4.1. GenScript
  - 10.4.1.1. Overview
  - 10.4.1.2. Financial Performance
  - 10.4.1.3. Method Benchmarking
  - 10.4.1.4. Strategic Initiatives
- 10.4.2. Azenta, Inc. (GENEWIZ)
  - 10.4.2.1. Overview
  - 10.4.2.2. Financial Performance
  - 10.4.2.3. Method Benchmarking
  - 10.4.2.4. Strategic Initiatives
- 10.4.3. Boster Biological Technology
  - 10.4.3.1. Overview
  - 10.4.3.2. Financial Performance
  - 10.4.3.3. Method Benchmarking
  - 10.4.3.4. Strategic Initiatives
- 10.4.4. Twist Bioscience
  - 10.4.4.1. Overview
  - 10.4.4.2. Financial Performance
  - 10.4.4.3. Method Benchmarking
  - 10.4.4.4. Strategic Initiatives
- 10.4.5. ProteoGenix, Inc
  - 10.4.5.1. Overview
  - 10.4.5.2. Financial Performance
  - 10.4.5.3. Method Benchmarking
  - 10.4.5.4. Strategic Initiatives
- 10.4.6. Biomatik.
  - 10.4.6.1. Overview
  - 10.4.6.2. Financial Performance
  - 10.4.6.3. Method Benchmarking
  - 10.4.6.4. Strategic Initiatives
- 10.4.7. ProMab Biotechnologies, Inc.
  - 10.4.7.1. Overview
  - 10.4.7.2. Financial Performance
  - 10.4.7.3. Method Benchmarking
  - 10.4.7.4. Strategic Initiatives
- 10.4.8. Thermo Fisher Scientific, Inc
  - 10.4.8.1. Overview
  - 10.4.8.2. Financial Performance
  - 10.4.8.3. Method Benchmarking
  - 10.4.8.4. Strategic Initiatives
- 10.4.9. Integrated DNA Technologies, Inc. (Danaher)
  - 10.4.9.1. Overview
  - 10.4.9.2. Financial Performance
  - 10.4.9.3. Method Benchmarking
  - 10.4.9.4. Strategic Initiatives
- 10.4.10. OriGene Technologies, Inc.
  - 10.4.10.1. Overview
  - 10.4.10.2. Financial Performance
  - 10.4.10.3. Method Benchmarking
  - 10.4.10.4. Strategic Initiatives

한글목차

유전자 합성(연구 용도) 시장 요약

목차

제1장 조사 방법과 범위

제2장 개요

제3장 시장 변수, 동향, 범위

제4장 유전자 합성(연구 용도) 시장 : 방법 추정·동향 분석

제5장 유전자 합성(연구 용도) 시장 : 서비스 추정·동향 분석

제6장 유전자 합성(연구 용도) 시장 : 용도 추정·동향 분석

제7장 유전자 합성(연구 용도) 시장 : 연구 단계 추정·동향 분석

제8장 유전자 합성(연구 용도) 시장 : 최종 용도 추정·동향 분석